This session was run by Mr John Zalcberg OAM (ACTA past-president) and included a presentation from Ms Megan Sanders (Executive Officer from the Thoracic Oncology Group of Australia), Ayla Barutchu from MAGNET and Donna Goldsmith from ANZICS Clinical Trial Group. The session covered principles of good governance and the specifics around CTN governance. The session also included practical examples of governance from the Australian and New Zealand Intensive Care Society (ANZICS), and the Mental Health Australia General Clinical Trial Network (MAGNET).
Latest Resource
-
CTN and CQR collaborations
-
ACTA Masterclass series on the Development of a Clinical Trial Network #1 – Establishment of a CTN
-
ACTA Masterclass series on Development of a Clinical Trial Network #3 – Funding
-
Case study: Networking and information were key in setting up NECST
-
Case study: How the Drug and Alcohol Clinical Research and Improvement Network (DACRIN) is enhancing consumer involvement in research
-
Case study: ACTA’s crucial contribution to the growth of the Mental Health Australia General Clinical Trial Network (MAGNET)
-
Workshop: How to better develop cross-network collaborations and linkages
-
Exploring greater partnership between Clinical Trial Networks, Clinical Quality Registries and Trial Coordinating Centres with Industry – Environmental Scan
-
Activities supporting the growth of Clinical Trial Networks in Australia
-
A pilot study to prospectively estimate the health and economic return on research investment
-
Fundraising strategy: guidance for CTNs
-
Communications and marketing strategy: guidance for CTNs
-
Communications and Marketing for Clinical Trials Networks: Website content management systems (CMS)
-
Communications and Marketing for Clinical Trials Networks: Social Media
-
Communications and Marketing for Clinical Trials Networks: Email Marketing
-
Communications and Marketing for Clinical Trials Networks: Data Dashboards
-
Business Review of CTNs
-
Risk Management: Guidance for Clinical Trial Networks
-
Trial safety oversight: Guidance for Clinical Trial Networks
-
Authorship and Publication Policy: Guidance for Clinical Trial Networks
-
Stakeholder Mapping for Clinical Trial Networks
-
Trial Endorsement and Review: Guidance for CTNs
-
Clinical Trial Network Executive Officer/Network Manager Duties
-
Clinical Trial Network Committee Terms of Reference
-
Establishment of New Clinical Trial Networks: Guidance for CTNs
-
Operational Self-Assessment Tool for CTNs
-
Trial Site Metrics Tool for CTNs
-
Activities critical to success and growth of Clinical Trials Networks: Sector consultation
-
Clinical Trial Network Strategic Plan Development
-
Clinical Trial Network Membership Structures
-
Clinical Trial Network Governance Structure